mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |